Abstract
BackgroundRecipients of haematopoietic stem cells are at high risk of developing invasive fungal disease (IFD) which is the leading cause of morbidity and mortality in these immunocompromised patients.Fluconazole and voriconazole...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have